(NASDAQ: HCWB) Hcw Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.19%.
Hcw Biologics's earnings in 2026 is -$22,206,013.On average, 3 Wall Street analysts forecast HCWB's earnings for 2026 to be -$3,168,985, with the lowest HCWB earnings forecast at -$3,044,711, and the highest HCWB earnings forecast at -$3,262,190. On average, 3 Wall Street analysts forecast HCWB's earnings for 2027 to be -$2,617,857, with the lowest HCWB earnings forecast at -$2,515,196, and the highest HCWB earnings forecast at -$2,694,853.
In 2028, HCWB is forecast to generate -$6,172,632 in earnings, with the lowest earnings forecast at -$5,930,568 and the highest earnings forecast at -$6,354,180.